Disease Areas
Local Coverage Determinations Roundup: Castle Bio, SkylineDx
Palmetto GBA released a final local coverage determination that covers tests from Castle Biosciences and SkylineDx.
Allogeneic Stem Cell Transplant Outcomes Improve With Diverse Gut Microbes, Immune Cells
By profiling the gut microbiome and blood immune cells, researchers found features linked to good outcomes and lower graft-versus-host disease rates.
CorePath Laboratories, Cizzle Biotechnology Partner on Lung Cancer Blood Test
CorePath will develop and offer UK-based Cizzle's test in the US, with royalty agreements on all product and services offerings related to the test.
Becton Dickinson Gets CE-IVD Mark for High-Throughput COVID/Flu PCR Test
The SARS-CoV-2/flu assay is the second test available on the high-throughput BD Cor PX/MX system.
Mitochondrial Protein Resource Reveals New Disease Players
Researchers developed a "mitochondrial orphan protein multi-omics" (MITOMICS) app by profiling proteins, lipids, and metabolites in cells lacking individual mitochondrial proteins.